Cerus Corp
CERS1.283USD
+0.013+1.03%
交易中 （美东）报价延迟15分钟
245.22M总市值
亏损市盈率 TTM
关于 Cerus Corp 公司
Cerus Corporation 是一家生物医学产品公司。该公司专注于开发和商业化 INTERCEPT 血液系统，以提高血液安全性。INTERCEPT 血液系统基于其控制生物复制的专有技术，旨在减少用于输血的捐献血液成分中的血源性病原体。其 INTERCEPT 血液系统旨在与血液成分及其某些衍生物一起使用：血小板、血浆、红细胞，并生产 INTERCEPT 纤维蛋白原复合物 (IFC) 和病原体减少血浆、冷沉淀减少。INTERCEPT 冷沉淀血液系统使用其血浆系统生产 IFC，用于治疗和控制与纤维蛋白原缺乏相关的出血，包括大出血。此外，INTERCEPT 冷沉淀血液系统用于生产病原体减少血浆、冷沉淀减少。
公司简介
公司代码CERS
公司名称Cerus Corp
上市日期Jan 31, 1997
CEOMr. William M. (Obi) Greenman
员工数量281
证券类型Ordinary Share
年结日Jan 31
公司地址1220 Concord Avenue
城市CONCORD
上市交易所NASDAQ Global Market Consolidated
国家United States of America
邮编94520
电话19252886000
网址https://www.cerus.com/
公司代码CERS
上市日期Jan 31, 1997
CEOMr. William M. (Obi) Greenman
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Eric H. Bjerkholt
Mr. Eric H. Bjerkholt
Independent Director
Independent Director
304.17K
+24.57%
Mr. Kevin Dennis Green, CPA
Mr. Kevin Dennis Green, CPA
Chief Financial Officer, Vice President - Finance
Chief Financial Officer, Vice President - Finance
289.70K
-64.05%
Ms. Ann Lucena
Ms. Ann Lucena
Independent Director
Independent Director
182.05K
+49.16%
Dr. Hua Shan, M.D., Ph.D.
Dr. Hua Shan, M.D., Ph.D.
Independent Director
Independent Director
131.10K
+84.39%
Mr. William M. (Obi) Greenman
Mr. William M. (Obi) Greenman
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Jami K. Nachtsheim ,
Jami K. Nachtsheim ,
Independent Director
Independent Director
--
--
Mr. Dean A. Gregory
Mr. Dean A. Gregory
Director
Director
--
--
Dr. Frank R. Witney, Ph.D.
Dr. Frank R. Witney, Ph.D.
Lead Independent Director
Lead Independent Director
--
--
Dr. Richard J. Benjamin, Ph.D.
Dr. Richard J. Benjamin, Ph.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Timothy L. (Tim) Moore
Mr. Timothy L. (Tim) Moore
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Eric H. Bjerkholt
Mr. Eric H. Bjerkholt
Independent Director
Independent Director
304.17K
+24.57%
Mr. Kevin Dennis Green, CPA
Mr. Kevin Dennis Green, CPA
Chief Financial Officer, Vice President - Finance
Chief Financial Officer, Vice President - Finance
289.70K
-64.05%
Ms. Ann Lucena
Ms. Ann Lucena
Independent Director
Independent Director
182.05K
+49.16%
Dr. Hua Shan, M.D., Ph.D.
Dr. Hua Shan, M.D., Ph.D.
Independent Director
Independent Director
131.10K
+84.39%
Mr. William M. (Obi) Greenman
Mr. William M. (Obi) Greenman
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Jami K. Nachtsheim ,
Jami K. Nachtsheim ,
Independent Director
Independent Director
--
--
收入明细
单位: USD更新时间: 7月6日 周日
单位: USD更新时间: 7月6日 周日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
Product
43.24M
0.00%
地区USD
名称
营收
占比
North America
30.60M
70.77%
Europe and Middle East and Africa
12.21M
28.24%
Other
427.00K
0.99%
业务
地区
业务USD
名称
营收
占比
Product
43.24M
0.00%
股东统计
更新时间: 5月22日 周四
更新时间: 5月22日 周四
持股股东
股东类型
持股股东
持股股东
占比
Baker Bros. Advisors LP
10.12%
ARK Investment Management LLC
10.05%
BlackRock Institutional Trust Company, N.A.
6.77%
The Vanguard Group, Inc.
5.52%
Wasatch Global Investors Inc
4.35%
Other
63.19%
持股股东
持股股东
占比
Baker Bros. Advisors LP
10.12%
ARK Investment Management LLC
10.05%
BlackRock Institutional Trust Company, N.A.
6.77%
The Vanguard Group, Inc.
5.52%
Wasatch Global Investors Inc
4.35%
Other
63.19%
股东类型
持股股东
占比
Investment Advisor
29.51%
Hedge Fund
20.42%
Investment Advisor/Hedge Fund
20.22%
Individual Investor
4.69%
Research Firm
3.80%
Family Office
1.22%
Venture Capital
0.10%
Bank and Trust
0.09%
Pension Fund
0.07%
Other
19.86%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
330
149.69M
78.31%
-11.42M
2025Q1
349
154.49M
80.95%
-4.85M
2024Q4
362
150.65M
81.09%
-18.33M
2024Q3
373
152.20M
82.15%
-11.01M
2024Q2
387
150.50M
81.41%
-12.83M
2024Q1
386
146.19M
80.62%
-12.96M
2023Q4
385
141.79M
78.32%
-24.31M
2023Q3
382
146.35M
81.02%
-13.17M
2023Q2
384
145.73M
80.79%
-19.32M
2023Q1
387
151.80M
85.48%
-8.28M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Baker Bros. Advisors LP
19.35M
10.12%
-126.25K
-0.65%
Mar 31, 2025
ARK Investment Management LLC
20.66M
10.81%
-159.61K
-0.77%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
12.94M
6.77%
+28.20K
+0.22%
Mar 31, 2025
The Vanguard Group, Inc.
10.55M
5.52%
+137.20K
+1.32%
Mar 31, 2025
Wasatch Global Investors Inc
8.32M
4.35%
--
--
Mar 31, 2025
Nikko Asset Management Co., Ltd.
6.19M
3.24%
-270.80K
-4.19%
Mar 31, 2025
Geode Capital Management, L.L.C.
4.54M
2.38%
+87.67K
+1.97%
Mar 31, 2025
Senvest Management, LLC
4.41M
2.3%
-1.99M
-31.10%
Mar 31, 2025
State Street Global Advisors (US)
3.80M
1.99%
-8.14K
-0.21%
Mar 31, 2025
D. E. Shaw & Co., L.P.
3.79M
1.98%
+361.80K
+10.55%
Mar 31, 2025
查看更多
持股ETF
更新时间: 8月2日 周六
更新时间: 8月2日 周六
机构名称
占比
ARK Genomic Revolution ETF
0.94%
Invesco NASDAQ Future Gen 200 ETF
0.5%
ARK Innovation ETF
0.23%
iShares Micro-Cap ETF
0.06%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.05%
Fidelity Enhanced Small Cap ETF
0.04%
iShares US Small-Cap Equity Factor ETF
0.04%
iShares Russell 2000 Growth ETF
0.02%
Global X Russell 2000 ETF
0.01%
Proshares Ultra Russell 2000
0.01%
查看更多
ARK Genomic Revolution ETF
占比0.94%
Invesco NASDAQ Future Gen 200 ETF
占比0.5%
ARK Innovation ETF
占比0.23%
iShares Micro-Cap ETF
占比0.06%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
占比0.05%
Fidelity Enhanced Small Cap ETF
占比0.04%
iShares US Small-Cap Equity Factor ETF
占比0.04%
iShares Russell 2000 Growth ETF
占比0.02%
Global X Russell 2000 ETF
占比0.01%
Proshares Ultra Russell 2000
占比0.01%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
